Long-Term Effects Secondary to Cancer Therapy in Children Completed Phase 0 Trials for Donepezil (DB00843)

IndicationStatusPhase
DBCOND0041542 (Long-Term Effects Secondary to Cancer Therapy in Children)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00452868Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the BrainSupportive Care